Treatment and prognostic factors in acute myeloid leukaemia

Bailliere's Clinical Haematology

Volumn 9, Issue 1, 1996, Pages 87-105

  Rowe, J M ^a   Liesveld, J L ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYTARABINE; DAUNORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; TREATMENT OUTCOME;

EID: 0029965191     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80038-2     Document Type: Article

References (103)

1. Appelbaum FR Fisher LD Thomas Ed Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: five year follow-up Blood 72 1988 79 184
2. Arlin Z Case DC Jr Moore J Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANNLL) Leukemia 4 1990 177 183
3. Bennett JM Andersen JW Cassileth PA Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group Leukemia Research 15 1991 223 227
4. Benyunes MC Massumoto C York A Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myclogenous leukemia Bone Marrow Transplantation 12 1993 159 163
5. Bergmann L Heil G Kolbe K Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemia Leukemia and Lymphoma 16 1995 271 279
6. Berman E Heller G Santorsa J Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia Blood 77 1991 1666 1674
7. Biggs JC Horowitz MM Gale RP Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy Blood 80 1992 1090 1093
8. Bishop JF Lowenthal RN Joshua D Etoposide in acute nonlymphocytic leukaemia Blood 75 1990 27 32
9. Bishop JF Young GA Szer J Randomized trial of high dose cytosine arabinoside (ara-C) combination in induction of acute myeloid leukemia (AML) Proceedings of the American Society of Clinical Oncology 11 1992 849
10. (abstract #849) Bishop JF Young GA Szer J Randomized trial of high dose cytosine arabinoside (ara-C) combination in induction of acute myeloid leukemia (AML) Proceedings of the American Society of Clinical Oncology 11 1992 260
11. (supplement) Bloomfield CD Lawrence D Arthur DC Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenic group Blood 84 1994 111a
12. Blume KG Kopecky KJ Henslee-Downey JP A prospective randomized comparison of total body irradiation/etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group Study Blood 81 1993 2187 2193
13. Brenner MK Rill DR Moen RC Gene-marking to trace origin of relapse after autologous bone marrow transplantation Lancet 431 1993 85 86
14. Büchner T Urbanitz D Hiddemann W Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group Journal of Clinical Oncology 3 1985 1583 1589
15. Campos L Gyotat D Archimbaud E Clinical significance of multidrug resistance P-glucoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis Blood 79 1992 473 476
16. Carella AM Martinengo M Santini G Idarubicin in combination with etoposide and cytarabine in adult untreated acute nonlymphoblastic leukemia European Journal of Cancer and Clinical Oncology 12 1987 1673 1678
17. Cassileth PA Begg CB Bennett JM A randomized study of the efficacy of consolidation therapy in adult acute non-lymphocytic leukemia Blood 63 1984 843 847
18. Cassileth PA Harrington DP Hines JD Maintenance chemotherapy prolongs remission duration in adult acute non-lymphocytic leukemia Journal of Clinical Oncology 6 1988 583 587
19. Cassileth PA Lynch E Hines JD Varying intensity of postremission therapy in acute myeloid leukemia Blood 79 1992 1924 1930
20. Cassileth PA Anderson JW Lazarus HM Autologous bone marrow transplantation in acute myeloid leukemia in first remission Journal of Clinical Oncology 11 1993 314 319
21. Champlin R Gajewski J Nimer S Postremission chemotherapy for adults with daunorubicin consolidation treatment Journal of Clinical Oncology 8 1990 1199 1206
22. Chao NJ Stein AS Long CD Bulsulfan/etoposide—initial experience with a new preparative regimen for autologous bone marrow transplantation in patients with acute non-lymphoblastic leukemia Blood 81 1993 319 323
23. Chopra R Goldstone AH McMillan KK Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow. The British Autograft Group Experience Journal of Clinical Oncology 9 1991 1840 1847
24. Clift RA Buckner CD Appelbaum FR Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia Journal of Clinical Oncology 10 1992 1723 1729
25. Daenen S Löwenberg B Sonneveld WL Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with Amsidine Leukemia 8 1994 6 10
26. Dillman RO Davis RB Green MR A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of cancer and leukemia group B Blood 78 1991 2520 2526
27. Dombret H Chastang C Fenaux P A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia New England Journal of Medicine 332 1995 1678 1683
28. Estey EH Use of colony-stimulating factors in the treatment of acute myeloid leukemia Blood 83 1994 1018 2015
29. Estey E Smith IL Keating MJ Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia Leukemia 3 1989 257 262
30. Estey E Thall PF Kantarjian H Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF Blood 79 1992 2246 2255
31. Estrov Z Kurzrock R Talpaz M Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia (review) Leukemia and Lymphoma 10 1993 407 418
32. Feldman E Arlin A Ahmed T Homoharringtonine is safe and effective for patients with acute myelogenous leukemia Leukemia 6 1992 1185 1188
33. Frenette PS Desforges JF Schenkein DP Granulocyte-macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia American Journal of Hematology 49 1995 48 55
34. Geller RB Saral R Piantadois S Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia Blood 73 1989 2209 2218
35. Gorin MC Labopin M Meloni G Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosphamide Leukemia 5 1991 896 904
36. Hamon MD Prentice HG Gottlieb DJ Immunotherapy with interleukin-2 after ABMT in AML Bone Marrow Transplantation 11 1993 399 401
37. Harousseau JL Milpied N Briere J Double intensive consolidation chemotherapy in adult acute myeloid leukemia Journal of Clinical Oncology 9 1991 1432 1437
38. Herweijer H Sonneveld P Baas F Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine Journal of the National Cancer Institute 82 1990 1133 1144
39. Herzig RH Lazarus HM Wolff SN High-dose cytosine arabinoside therapy with and without antracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia Journal of Clinical Oncology 3 1985 992 997
40. Ho AD Bernadett B Haas R Etoposide in acute leukemia: past experience and future perspectives Cancer 67 1991 281 284
41. Horowitz MM Gale RP Sondel PM Graft-versus-leukemia reactions after bone marrow transplantation Blood 79 1990 555 562
42. Inatomi Y Toyama K Clark SC Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia Cancer Research 54 1994 455 462
43. Keating MJ Kantarjian H Smith TL Response to salvage therapy after relapse in acute myelogenous leukemia Journal of Clinical Oncology 7 1989 1071 1080
44. Keating MJ Estey E Kantarjian H Evolution of treatment for acute myelogenous leukemia and myelodysplastic leukemia Journal of Clinical Oncology 7 1992 1071 1080
45. Keller RP Altermatt DH Donatsch P Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16–213) enhance in vivo cytostatic activity and toxicity International Journal of Cancer 51 1992 422 438
46. Korbling M Fliedner TM Holle R Autologous blood stem cell versus purged bone marrow transplantation in standard risk AML: influence of source and composition of the autograft on hemopoietic reconstitution and disease-free survival Bone Marrow Transplantation 7 1991 343 349
47. Lazarus HM Rowe JM Goldstone AH Does in vitro bone marrow purging improve the outcome after autologous bone marrow transplantation Journal of Hematotherapy 2 1993 457 460
48. Linker CA Ries CA Damon LE Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen Blood 81 1993 311 318
49. List AF Spier C Greer J Phase I/II trial of cyclosporine as a chemotherapy resistance modifier in acute leukemia Journal of Clinical Oncology 11 1993 1652 1660
50. Löwenberg B van Putten WW LJ Touw IP Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia New England Journal of Medicine 328 1993 614 619
51. Lum BL Fisher GA Brophy NA Clinical trials of modulation of multidrug resistance: pharmacokinetic and pharmacodynamic considerations Cancer 72 1993 3502 3514
52. McGlave PB Haake RJ Bodstrom BC Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission Blood 72 1988 1512 1517
53. McMillan AK Goldstone AH Linch DC High-dose chemotherapy in autologous bone marrow transplantation in acute myeloid leukemia Blood 76 1990 480 488
54. Maharaj D Guerra M Morrell L Chemotherapy/G-CSF primed peripheral blood stem cells alone are sufficient for rapid hematopoietic reconstitution of platelets and myeloid cells after myeloablative therapy Blood 82 supplement 1 1993 83a
55. Mandelli F Vignetti M Tosti S Interleukin-2 treatment in acute myelogenous leukemia Stem Cells 11 1993 263 268
56. Marie JP Zittoun R Sikic BI Multidrug resistance (mdr 1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity Blood 78 1991 586 592
57. Mayer RJ Schiffer CA Peterson BA Intensive post remission therapy in adults with acute non-lymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB Seminars in Oncology 14 2 1987 25 31 (supplement)
58. Mayer RJ Davis RB Schiffer CA Intensive postremission chemotherapy in adults with acute myeloid leukemia New England Journal of Medicine 331 1994 896 903
59. Meloni G Foa R Vignetti M Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia Blood 84 1994 2158 2163
60. Nemunaitis J Appelbaum RN Lilleby K Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia Blood 83 1994 3473 3479
61. Ohno R Tomonaga M Kobayashi T Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia New England Journal of Medicine 323 1990 871 877
62. Omura GA Vogler WR Lefante J Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy Cancer 49 1982 1530 1536
63. Peterson FB Lynch MHE Clift RA Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or second remission Journal of Clinical Oncology 11 1993 1353 1360
64. Petti MC Mandelli F Zagonel V A pilot study of 5-aza-2′-deoxycytidine (Decitabine) in treatment of poor prognosis acute myelogenous leukemia patients: preliminary results Leukemia 7 1993 36 41
65. Phillips GL Reece DE Shepherd JD High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults Blood 77 1991 1429 1435
66. Preisler HD Anderson K Rai K The frequency of long-term remission in patients with acute myelogenous leukemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of six years British Journal of Haematology 71 1989 189 194
67. Prentice HG McDonald ID Hamon MD The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia Progress in Clinical and Biological Research 389 1994 239 243
68. Raza A Preisler HD Day I Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics. A leukemia intergroup study Blood 76 1990 2191 2197
69. Reiffers J Gasparo MH Maraninchi D Comparison of allogeneic bone marrow transplantation and chemotherapy in patients with acute myeloid I leukemia in first remission: a prospective controlled trial British Journal of Haematology 72 1989 57 63
70. Reuter C Auf der Landwehr U Schleyer E Modulation of intracellular metabolism in cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor Leukemia 8 1994 217 225
71. Ringdon O Horowitz MM Graft-vs-leukemia reactions in humans Transplantation Proceedings 21 1989 2989 2995
72. Rizzoli V Mangoni L Carlo-Stella C Autologous bone marrow transplantation in acute myelogenous leukemia Leukemia 6 1992 1101 1106
73. Rowe JM Chang AYC Bennett JM Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia Blood 71 1988 992 996
74. Rowe JM Cassileth PA Oken MM Clinical trials in adults with acute myelogneous leukemia: the ECOG experience Gale RP Acute Myelogenous Leukemia: Progress and Controversies 1990 Wiley-Liss New York 293 302
75. Rowe JM Nilsson BI Simonsson B Treatment of minimal residual disease in myeloid leukemia—the immunotherapeutic options with emphasis on Linomide Leukemia and Lymphoma 11 1993 321 329
76. Rowe JM Andersen JW Mazza JJ Treatment of relapsed and refractory AML with mitoxantrone and etoposide: a study of the Eastern Cooperative Oncology Group Bücher T Hiddleman W Wörmann B Acute Leukemias IV: Prognostic Factors 1994 Springer-Verlag Berlin 235 238
77. Rowe JM Andersen JW Cassileth PA Clinical trials in adults with acute myelogenous leukemia: experience of the Eastern Cooperative Oncology Group Bücher T Hiddemann W Wörmann B Acute Leukemias IV: Prognostic Factors 1994 Springer-Verlag, Heidelberg Berlin 541 546
78. Rowe JM Anderson JW Mazza JJ A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogeneous leukemia: a study of the Eastern Cooperative Oncology Group (E1490) Blood 86 1995 457 462
79. Santana VM Marrow J Kearns C 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia Journal of Clinical Oncology 10 1992 364 370
80. Sanz MA Rubia J Sanz GF Busulfan plus cyclosphosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution Journal of Clinical Oncology 11 1993 1661 1667
81. Schiffer CA Lee EJ Romiyasu T Prognostic impact on cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia Blood 73 1989 263 270
82. Schiller GJ Nimer SD Territo MC Bone marrow transplantation versus high dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission Journal of Clinical Oncology 10 1992 41 46
83. Schiller G Gajewski J Nimer S Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia Blood 80 1992 2977 2982
84. Schiller G Feig SA Territo M Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation British Journal of Haematology 88 1994 72 78
85. Schneider E Cowan KH Bader H Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia Blood 85 1995 186 193
86. Short T Miller KR Desforges JD The predictive value of in vitro techniques in acute nonlymphocytic leukemia Leukemia Research 11 1987 687 691
87. +/DR phenotypes with shorter survival. Groupe d'Etude Immunologique des Llencemie (Geil) Leukemia 6 1992 393 399
88. Stone MS Berg DT George SL Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia New England Journal of Medicine 332 1995 1671 1677
89. Szer J Grigg AP Phillips GL Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT Bone Marrow Transplantation 11 1993 109 111
90. + acute myeloid leukemia cells Blood 82 1993 3157 3162
91. Tsururo R Lida H Tsukagoshi S Increased accumulation of vincristine and adriamycin in drug-resistant P322 tumor cells following incubation with calcium antagonists and calmodulin inhibitors Cancer Research 42 1982 4730 4733
92. Visani G Tosi P Zinzani PL FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of ‘poor risk’ acute myeloid leukemias Leukemia 8 1994 1842 1846
93. Vogler WR Harrington DP Winton EF Phase II clinical trial of carboplatin in relapsed and refractory leukemia Leukemia 6 1992 1072 1073
94. Vogler WR Velez-Garcia E Weiner RS A phase III trial comparing idarubicin and daunorubicin in acute myelogenous leukemia: a Southeastern Cancer Study Group study Journal of Clinical Oncology 10 1992 1103 1111
95. Vogler WR McCarley DL Stagg M A phase III trial of high-dose cytosine arabinosine with or without etoposide in relapsed and refractory acute myelogneous leukemia. A Southeastern Cancer Study Group Trial Leukemia 8 1994 1847 1853
96. (abstract #261) Weick J Kopecky K Appelbaum F A randomized investigation of high-dose (HDAC) versus standard dose (SDAC) cytosine arabinoside with daunorubicin (DNR) in patients with acute myelogenous leukemia Proceedings of the American Society for Clinical Oncology 11 1992 856
97. Wiernik PH Bands PLC Case DC Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia Blood 79 1992 313 319
98. Wolff SN Herzig RH Fay JW High dose cytosabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long term follow-up and results Journal of Clinical Oncology 7 1989 1260 1267
99. Yahanda AM Adler KM Fisher GA A phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance Journal of Clinical Oncology 10 1992 1624 1634
100. Yamada K Furusawa S Saito K Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study Leukemia 9 1995 10 14
101. Yates J Glidewell O Wiernik P Cytosine arabinoside with daunorubicin or Adriamycin for therapy of acute myelocytic leukemia: a CALGB study Blood 60 1982 454 462
102. Yeager AM Kaizer H Santos GW Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide New England Journal of Medicine 315 1986 141 147
103. Zittoun RA Mandelli F Willemze R Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia New England Journal of Medicine 323 1995 260 262